What's driving the Mice Model Market Size? | Top Key Players genOway, Envigo, Charles River, Janvier Labs, Transviragen Inc., Transpogen Biopharmaceutical, Inc., and Taconic Biosciences Inc.

The U.S. mice model market trends are projected showcase a significant growth rate of 8% over the analysis period. Increasing research studies for finding the root cause of cardiovascular diseases, cancer, and metabolic disorders are fueling the demand for mice models in the country. Moreover, presence of an established biomedical industry in the U.S will further lead to enhanced research activities on mice model in the future.

In terms of revenue, mice model market size is forecast to surpass USD 11.7 billion by 2025 with a notable CAGR of 8% over 2019- 2025. The rising need to understand the genetic variations on which human diseases manifest along with rise in number of testing procedures on mice models for certifying drug safety may fuel mice model industry growth in the coming years.
Global Market Insights, Inc. predicts that the mice model market should increase from $6.9 billion in 2018 to $11.7 billion in 2025 at a compound annual growth rate (CAGR) of 7.7% for 2019-2025.

Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/4473

Global mice model market is deriving massive growth from towering adoption of mice models for various research investigations. Rising prevalence of cancer, autoimmune disorders, and cardiovascular diseases are prompting various research studies. Mice possess almost 95% genetic similarity with humans due to which they are among the most preferred models for understanding the mechanism and cause of diseases occurring in humans. Mice models are widely used as basic models for the study of human reproduction.

Based on mice type, mice model market is segmented into outbred, inbred, hybrid, knockout, and others. In 2018, inbred mice model industry held the maximum share of over 27%. These models are experiencing heavy demand from cancer research programs as mice models are designed for the testing of compounds, that manipulate the immune system to assist in fighting cancer. Inbred mice models also aid researchers in understanding the mechanism of disease.
On the basis of technology, mice model market is bifurcated into CRISPR, embryonic nuclear transfer, stem cell, microinjection, and others. Out of all these technologies, the CRISPR technology held the major share of over 32.7% in 2018. Robust adoption of the technology can be attributed to several advantages aligned with it, including cost-effectiveness, ease of use, time saving, and greater efficiency to change target genes when compared to other gene targeting technologies.

Speaking in terms of usage, mice model market is segmented into veterinary and human. The human segment dominated the global market in 2018 with over 80% share. For understanding the mechanism of deadly diseases, such as diabetes, cancer and cardiovascular diseases, which result in loss of millions of lives every year, the number of testing procedures on mice models is escalating. Moreover, widespread utilization of these models for understanding the biological behavior of neurological disorders and autoimmune diseases is likely to boost segmental growth.

Considering the end use spectrum of the market, companies held the highest share of more than 62.1% in the overall market. Rise in number of R&D activities in the biotech and pharma industries along with rapid growth in the pipeline drugs marketplace, which demands animal testing for validating the efficacy and safety of drugs, as well as for the development of novel vaccines, may change industry trends.

Browse Report Summary @ https://www.gminsights.com/industry-analysis/mice-model-market

Key industry players operating in the mice model market include genOway, Envigo, Charles River, Janvier Labs, Transviragen Inc., Transpogen Biopharmaceutical, Inc., and Taconic Biosciences Inc.

More Insightful Info: https://www.marketwatch.com/press-release/mice-model-market-2019-opportunity-analysis-and-industry-forecast-by-2025-2020-01-16

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com/

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.